Financial giants have made a conspicuous bullish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson JNJ revealed 12 unusual trades.
Delving into the details, we found 50% of traders were bullish, while 33% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $253,641, and 8 were calls, valued at $331,879.
Projected Price Targets
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $140.0 to $170.0 for Johnson & Johnson during the past quarter.
Analyzing Volume & Open Interest
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Johnson & Johnson's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Johnson & Johnson's significant trades, within a strike price range of $140.0 to $170.0, over the past month.
Johnson & Johnson Option Activity Analysis: Last 30 Days
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | PUT | SWEEP | BULLISH | 03/21/25 | $3.1 | $3.05 | $3.05 | $165.00 | $128.7K | 1.7K | 722 |
| JNJ | CALL | TRADE | BEARISH | 07/17/26 | $31.05 | $30.25 | $30.25 | $140.00 | $60.5K | 21 | 20 |
| JNJ | CALL | TRADE | BEARISH | 07/18/25 | $26.2 | $25.65 | $25.65 | $140.00 | $51.3K | 50 | 20 |
| JNJ | PUT | SWEEP | BEARISH | 05/16/25 | $5.05 | $4.9 | $5.05 | $165.00 | $50.5K | 129 | 128 |
| JNJ | CALL | SWEEP | NEUTRAL | 03/21/25 | $2.2 | $2.16 | $2.19 | $165.00 | $48.4K | 8.2K | 806 |
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
Current Position of Johnson & Johnson
- Currently trading with a volume of 3,345,001, the JNJ's price is down by -1.66%, now at $163.34.
- RSI readings suggest the stock is currently may be approaching overbought.
- Anticipated earnings release is in 48 days.
Expert Opinions on Johnson & Johnson
3 market experts have recently issued ratings for this stock, with a consensus target price of $171.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * An analyst from Guggenheim has decided to maintain their Neutral rating on Johnson & Johnson, which currently sits at a price target of $166. * In a cautious move, an analyst from RBC Capital downgraded its rating to Outperform, setting a price target of $181. * An analyst from Barclays persists with their Equal-Weight rating on Johnson & Johnson, maintaining a target price of $166.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Johnson & Johnson, Benzinga Pro gives you real-time options trades alerts.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
